Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features

Multiple Sclerosis Journal

Volumn 19, Issue 11, 2013, Pages 1437-1442

  Frau, J ^a   Cossu, D ^b   Coghe, G ^a   Lorefice, L ^a   Fenu, G ^a   Melis, M ^a   Paccagnini, D ^b   Sardu, C ^a   Murru, M R ^a   Tranquilli, S ^a   Marrosu, M G ^a   Sechi, L A ^b   Cocco, E ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

infectious factors; molecular mimicry; multiple sclerosis; Mycobacterium avium subspecies paratuberculosis; pathogenesis; Sardinia

Indexed keywords

BACTERIUM ANTIBODY; MAP2694 ANTIBODY; MAPDNA ANTIBODY; OLIGOCLONAL BAND; STEROID; UNCLASSIFIED DRUG;

ADULT; AGE; ANTIBODY DETECTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; ONSET AGE; PARATUBERCULOSIS; RELAPSE; STEROID THERAPY;

INFECTIOUS FACTORS; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; MYCOBACTERIUM AVIUM SUBSPECIES PARATUBERCULOSIS; PATHOGENESIS; SARDINIA;

ADULT; ANTIBODIES, BACTERIAL; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; ITALY; MALE; MULTIPLE SCLEROSIS; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; PARATUBERCULOSIS; POLYMERASE CHAIN REACTION;

EID: 84880396663     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513477926     Document Type: Article

References (35)

1. Kurtzke JF. MS epidemiology world wide. One view of current status. Acta Neurol Scand Suppl. 1995 ; 161: 23-33
2. Casetta I, Granieri E, Marchi D, et al. An epidemiological study of multiple sclerosis in central Sardinia, Italy. Acta Neurol Scand. 1998 ; 98: 391-394
3. Sardu C, Cocco E, Mereu A, et al. Population based study of 12 autoimmune diseases in Sardinia, Italy: Prevalence and comorbidity. PLoS One. 2012 ; 7: e32487
4. Cocco E, Sardu C, Massa R, et al. Epidemiology of multiple sclerosis in south-western Sardinia. Mult Scler. 2011 ; 17: 1282-1289
5. Marrosu MG, Murru R, Murru MR, et al. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet. 2001 ; 10: 2907-2916
6. Lampis R, Morelli L, De Virgiliis S, et al. The distribution of HLA class II haplotypes reveals that the Sardinian population is genetically differentiated from the other Caucasian populations. Tissue Antigens. 2000 ; 56: 515-521
7. Cocco E, Sardu C, Pieroni E, et al. HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia. PLoS One. 2012 ; 7: e33972
8. Oksenberg JR, Barcellos LF. The complex genetic aetiology of multiple sclerosis. J Neurovirol. 2000 ; 6: S10 - S14
9. Hawkes CH, Macgregor AJ. Twin studies and the heritability of MS: A conclusion. Mult Scler. 2009 ; 15: 661-667
10. Gale CR, Martyn CN. Migrant studies in multiple sclerosis. Prog Neurobiol. 1995 ; 47: 425-448
11. Hammond SR, English DR, McLeod JG. The age-range of risk of developing multiple sclerosis: Evidence from a migrant population in Australia. Brain. 2000 ; 123 (Pt 5). 968-974
12. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol. 2007 ; 61: 288-299
13. Leibowitz U, Antonovsky A, Medalie JM, et al. Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation. J Neurol Neurosurg Psychiatry. 1966 ; 29: 60-68
14. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002 ; 347: 911-920
15. Hafler DA. The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis. J Clin Invest. 1999 ; 104: 527-529
16. Hunter SF, Hafler DA. Ubiquitous pathogens: Links between infection and autoimmunity in MS?. Neurology. 2000 ; 55: 164-165
17. Fujinami RS, Oldstone MB. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity. Science. 1985 ; 230: 1043-1045
18. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell. 1995 ; 80: 695-705
19. Cossu D, Cocco E, Paccagnini D, et al. Association of Mycobacterium avium subsp. paratuberculosis with multiple sclerosis in Sardinian patients. PLoS One. 2011 ; 6: e18482
20. Cossu D, Masala S, Cocco E, et al. Are Mycobacterium avium subsp. paratuberculosis and Epstein-Barr virus triggers of multiple sclerosis in Sardinia?. Mult Scler. 2012 ; 18: 1181-1184
21. Sechi LA, Gazouli M, Ikonomopoulos J, et al. Mycobacterium avium subsp. paratuberculosis, genetic susceptibility to Crohn's disease, and Sardinians: The way ahead. J Clin Microbiol. 2005 ; 43: 5275-5277
22. Rosu V, Ahmed N, Paccagnini D, et al. Specific immunoassays confirm association of Mycobacterium avium Subsp. paratuberculosis with type-1 but not type-2 diabetes mellitus. PLoS One. 2009 ; 4: e4386
23. Sechi LA, Rosu V, Pacifico A, et al. Humoral immune responses of type 1 diabetes patients to Mycobacterium avium subsp. paratuberculosis lend support to the infectious trigger hypothesis. Clin Vaccine Immunol. 2008 ; 15: 320-326
24. Marrosu MG, Motzo C, Murru R, et al. The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone. Hum Mol Genet. 2004 ; 13: 2919-2924
25. Marrosu MG, Cocco E, Lai M, et al. Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: A cohort study. Lancet. 2002 ; 359: 1461-1465
26. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011 ; 69: 292-302
27. Rani PS, Sechi LA, Ahmed N. Mycobacterium avium subsp. paratuberculosis as a trigger of type-1 diabetes: Destination Sardinia, or beyond. Gut Pathog. 2010 ; 2: 1
28. Nagarajan U. Induction and function of IFNβ during viral and bacterial infection. Crit Rev Immunol. 2011 ; 31: 459-474
29. Bech E, Lycke J, Gadeberg P, et al. A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. Neurology. 2002 ; 58: 31-36
30. Friedman JE, Zabriskie JB, Plank C, et al. A randomized clinical trial of valacyclovir in multiple sclerosis. Mult Scler. 2005 ; 11: 286-295
31. Lycke J, Svennerholm B, Hjelmquist E, et al. Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study. J Neurol. 1996 ; 243: 214-224
32. Hultén K, Almashhrawi A, El-Zaatari FA, et al. Antibacterial therapy for Crohn's disease: A review emphasizing therapy directed against mycobacteria. Dig Dis Sci. 2000 ; 45: 445-456
33. Gui GP, Thomas PR, Tizard ML, et al. Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. J Antimicrob Chemother. 1997 ; 39: 393-400
34. Graham DY, Al-Assi MT. Prolonged remission in Crohn's disease following therapy for Mycobacterium paratubercolosis infection. Gastroenterology. 1995 ; 108: A826
35. Chamberlin W, Graham DY, Hulten K, et al. Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease. Aliment Pharmacol Ther. 2001 ; 15: 337-346